Literature DB >> 7207203

The determination of glycosylated hemoglobins in rats using high pressure liquid chromatography.

M H Blanc, F H Rhie, P J Dunn, J S Soeldner.   

Abstract

Glycosylated hemoglobins (GHb) or fast hemoglobins (FH) are minor components of hemoglobin that so far have been quantified in men, monkeys, and mice, and they are elevated in diabetic subjects of all these species. Since the rat is a useful model for experimental diabetic studies, hemolysates from streptozotocin-induced diabetic rats were analyzed for FH fractions using a high pressure liquid chromatography method. In a long-term study (3 mo), the maximal increment of the FH fractions was achieved after 5 wk of diabetes (from 5.67% +/- 0.41% SD to 10.80% +/- 0.74%) supporting the notion that the biosynthesis of these compounds occurs continuously during the lifespan of the red cell. In a short-term study, however, an elevation of the FH by 11% after 2 days and by 26% after 6 days of diabetes was noticed suggesting that a rapid increase of the FH may occur in relation to rapid changes of the glucose level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7207203     DOI: 10.1016/0026-0495(81)90108-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

2.  HbA1 in assessment of metabolic control in diabetic BB/E rats.

Authors:  F J Tames; J D Baird; A J Bone
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

3.  Absence of rapid glycosylation of rat haemoglobin.

Authors:  O Rácz; M Riemerová
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

4.  Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport.

Authors:  E B Chang; R M Bergenstal; M Field
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.